Zacks Research upgraded shares of DocGo (NASDAQ:DCGO – Free Report) from a strong sell rating to a hold rating in a report published on Thursday,Zacks.com reports.
Several other brokerages have also recently commented on DCGO. Canaccord Genuity Group raised their target price on DocGo from $1.45 to $1.60 and gave the stock a “hold” rating in a research report on Thursday, August 21st. Weiss Ratings reissued a “sell (d)” rating on shares of DocGo in a research note on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $3.24.
View Our Latest Report on DCGO
DocGo Trading Up 3.7%
DocGo (NASDAQ:DCGO – Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.05). DocGo had a negative net margin of 4.20% and a negative return on equity of 3.26%. The firm had revenue of $80.42 million during the quarter, compared to analysts’ expectations of $77.58 million. On average, analysts expect that DocGo will post 0.25 earnings per share for the current fiscal year.
Institutional Trading of DocGo
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Summit Securities Group LLC acquired a new position in shares of DocGo during the 1st quarter valued at about $34,000. CWM LLC lifted its holdings in DocGo by 2,613.3% in the 2nd quarter. CWM LLC now owns 21,978 shares of the company’s stock worth $35,000 after purchasing an additional 21,168 shares during the last quarter. Cerity Partners LLC bought a new stake in DocGo during the second quarter worth approximately $37,000. Strs Ohio acquired a new position in DocGo during the first quarter valued at approximately $76,000. Finally, Engineers Gate Manager LP acquired a new position in DocGo during the second quarter valued at approximately $52,000. Institutional investors and hedge funds own 56.44% of the company’s stock.
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
- Five stocks we like better than DocGo
- Ride Out The Recession With These Dividend Kings
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- What is a Special Dividend?
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
- What is a Death Cross in Stocks?
- Qualcomm Earnings Surprise Wall Street—Here’s What Q4 Could Deliver
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
